Recent studies have also shown that sustained STAT3 activation is mediated by IL-6 in ovarian carcinoma, cholangiocarcinoma, colon cancer and lung adenocarcinoma [32]–[35]. Here, STAT3 is linked to lung adenocarcinoma.